The pharmaceutical industry’s lobbying muscle scored a high-stakes victory on Monday when the Senate parliamentarian reversed a previous decision and ruled that the Optimizing Research Progress Hope ...

After being abandoned by his parents and surviving the foster system, a brilliant teen hacker is lured into cybercrime by a manipulative mentor. When an elderly neighbor shows him true kindness, he ...

HC Wainwright initiated coverage on Aardvark Therapeutics, Inc. (NASDAQ:AARD) on Monday with a Buy rating and a price ...

U.S. job openings rose unexpectedly in May, a sign that the American labor market remains resilient in the face of high ...

Shortly after making a memorable cameo on The Bear, this Carry-On star's recent horror flick is climbing the streaming charts ...

Cool-looking headphones with a competitive price that hold their own against AirPods Max. When I first saw leaks of Nothing’s ...

The PHOENIX study is a 24-month, randomized, double-masked, placebo-controlled, multicenter, pivotal Phase 3 trial. The study is ongoing across sites in the United States, the United Kingdom, France, ...

Oncternal Therapeutics, Inc. today announced the sale of its zilovertamab and ONCT-808 programs to Ho’ola Therapeutics, Inc. Zilovertamab is an investigational monoclonal antibody designed to inhibit ...

Federal Reserve Chair Jerome Powell is sticking to his position that the central bank will keep its key rate on hold while it waits to see how President Donald Trump’s tariffs effect the ...

Enzyme Replacement Therapy for Pompe Disease Market to Reach $350 Million by 2025, Driven by Expanding Clinical Applications The global enzyme replacement therapy (ERT) targeting Pompe disease market ...